Login to Your Account

Bone bid from Mereo sets forth, phase IIb taking aim at OI

By Randy Osborne
Staff Writer

Thursday, May 4, 2017

With phase II trials ongoing in COPD and low testosterone in obese men, Mereo Biopharma Group plc is launching a potentially pivotal phase IIb experiment called Asteroid testing BPS-804 in adults with OI, also known as brittle bone disease.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription